BioNano Genomics, Inc. (BNGO) Reports Q4 Revenue of $4M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Bionano Genomics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates
March 23, 2021 4:01 PM EDT-Solidified Financial Position Raising Approximately $335 Million in Q1 2021
-Executed on Commercial Offerings for Saphyr®, Driving Towards Global Adoption
-Conference Call Today, March 23, 2021, at 4:30 pm EST
SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results and business achievements for the fourth quarter and year ended December 31, 2020 and highlighted recent corporate updates.
2020 was an important momentum-building year for Bionano and one that allowed us to... More



